274 related articles for article (PubMed ID: 28187435)
1. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis.
Wang J; Ye C; Chen C; Xiong H; Xie B; Zhou J; Chen Y; Zheng S; Wang L
Oncotarget; 2017 Mar; 8(10):16875-16886. PubMed ID: 28187435
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.
Yu M; Yongzhi H; Chen S; Luo X; Lin Y; Zhou Y; Jin H; Hou B; Deng Y; Tu L; Jian Z
Oncotarget; 2017 Jun; 8(26):43356-43367. PubMed ID: 28498810
[TBL] [Abstract][Full Text] [Related]
3. Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas.
Komaki S; Sugita Y; Furuta T; Yamada K; Moritsubo M; Abe H; Akiba J; Miyagi N; Nakamura H; Miyoshi H; Ohshima K; Morioka M
J Neuropathol Exp Neurol; 2019 May; 78(5):389-397. PubMed ID: 30990881
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis.
Tohma T; Okazumi S; Makino H; Cho A; Mochizuki R; Shuto K; Kudo H; Matsubara K; Gunji H; Matsubara H; Ochiai T
Dis Esophagus; 2005; 18(3):185-9. PubMed ID: 16045581
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of fibroblast growth factor receptor 2 in human solid tumors: A systematic review and meta-analysis.
Liu G; Xiong D; Xiao R; Huang Z
Tumour Biol; 2017 Jun; 39(6):1010428317707424. PubMed ID: 28618942
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of GLUT1 in breast cancer: A meta-analysis.
Deng Y; Zou J; Deng T; Liu J
Medicine (Baltimore); 2018 Nov; 97(48):e12961. PubMed ID: 30508885
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis.
Shen YM; Arbman G; Olsson B; Sun XF
Int J Biol Markers; 2011; 26(3):166-72. PubMed ID: 21786248
[TBL] [Abstract][Full Text] [Related]
9. GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.
Sun HW; Yu XJ; Wu WC; Chen J; Shi M; Zheng L; Xu J
PLoS One; 2016; 11(12):e0168907. PubMed ID: 28036362
[TBL] [Abstract][Full Text] [Related]
10. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis.
Zeng P; Wang YH; Si M; Gu JH; Li P; Lu PH; Chen MB
Oncotarget; 2017 Jan; 8(3):5592-5602. PubMed ID: 27888619
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.
Li L; Wu D; Yu Q; Li L; Wu P
Oncotarget; 2017 May; 8(19):32298-32308. PubMed ID: 28427178
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.
Wu P; Wu D; Zhao L; Huang L; Shen G; Huang J; Chai Y
Oncotarget; 2016 Apr; 7(15):19863-83. PubMed ID: 26959884
[TBL] [Abstract][Full Text] [Related]
13. Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
Tan Z; Yang C; Zhang X; Zheng P; Shen W
Oncotarget; 2017 Sep; 8(37):60954-60961. PubMed ID: 28977837
[TBL] [Abstract][Full Text] [Related]
14. The association of (18)F-FDG PET and glucose metabolism biomarkers GLUT1 and HK2 in p16 positive and negative head and neck squamous cell carcinomas.
Baschnagel AM; Wobb JL; Dilworth JT; Williams L; Eskandari M; Wu D; Pruetz BL; Wilson GD
Radiother Oncol; 2015 Oct; 117(1):118-24. PubMed ID: 26328941
[TBL] [Abstract][Full Text] [Related]
15. Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis.
Zhao S; Wu D; Wu P; Wang Z; Huang J
PLoS One; 2015; 10(10):e0139598. PubMed ID: 26440936
[TBL] [Abstract][Full Text] [Related]
16. High expression of glucose transporter 1 on primary lesions of esophageal squamous cell carcinoma is associated with hematogenous recurrence.
Sawayama H; Ishimoto T; Watanabe M; Yoshida N; Baba Y; Sugihara H; Izumi D; Kurashige J; Baba H
Ann Surg Oncol; 2014 May; 21(5):1756-62. PubMed ID: 24242681
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of cyclin B1 in solid tumors: a meta-analysis.
Ye C; Wang J; Wu P; Li X; Chai Y
Oncotarget; 2017 Jan; 8(2):2224-2232. PubMed ID: 27903976
[TBL] [Abstract][Full Text] [Related]
18. Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis.
Zeng P; Chen MB; Zhou LN; Tang M; Liu CY; Lu PH
Sci Rep; 2016 Sep; 6():33658. PubMed ID: 27645103
[TBL] [Abstract][Full Text] [Related]
19. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A
Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955
[TBL] [Abstract][Full Text] [Related]
20. Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors.
Mori Y; Tsukinoki K; Yasuda M; Miyazawa M; Kaneko A; Watanabe Y
Oral Oncol; 2007 Jul; 43(6):563-9. PubMed ID: 17071132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]